UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

In a report released today, Charles Pitman CFA from Barclays reiterated a Buy rating on UCB SA (0NZT – Research Report), with a price target of ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes? Let's find out.

In a report released today, Catherine Mealor from KBW maintained a Hold rating on United Community Banks (UCB – Research Report), with a price ...

UCB SA (OTCMKTS:UCBJY – Get Free Report)’s stock price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $96.49 and traded as low as $93.22.

DA Davidson raised their FY2025 earnings estimates for shares of United Community Banks in a report issued on Thursday, January 23rd. DA Davidson analyst G. Tenner now anticipates that the company ...

UCB’s 320 mg/2 mL prefilled syringe and autoinjector for single-injection administration option is available now in US: Brussels, Belgium Saturday, January 18, 2025, 16:00 Hrs [ ...

UCB showcases decade of growth and Patient Value Strategy driving differentiated innovationBreakthrough innovation, differentiated solutions and cutting-edge pipeline to unlock growth for a decade+ ...

While the top- and bottom-line numbers for United Community Banks (UCB) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key ...

Nitin Sahney, co-founder and CEO of PharmaCord, poses for a portrait in the pharmaceutical support company’s new headquarters ...

Good morning, and welcome to United Community Banks’ Fourth Quarter 2024 Earnings Call. Hosting our call today are Chairman and Chief Executive Officer, Lynn Harton; Chief Financial Officer, Jefferson ...